IS5999A - Beinvaxtarörvandi þáttur - Google Patents

Beinvaxtarörvandi þáttur

Info

Publication number
IS5999A
IS5999A IS5999A IS5999A IS5999A IS 5999 A IS5999 A IS 5999A IS 5999 A IS5999 A IS 5999A IS 5999 A IS5999 A IS 5999A IS 5999 A IS5999 A IS 5999A
Authority
IS
Iceland
Prior art keywords
growth factor
bone growth
bone
factor
growth
Prior art date
Application number
IS5999A
Other languages
English (en)
Inventor
Shing Tam Cherk
Original Assignee
Osteopharm Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteopharm Inc. filed Critical Osteopharm Inc.
Publication of IS5999A publication Critical patent/IS5999A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IS5999A 1999-01-13 2001-07-11 Beinvaxtarörvandi þáttur IS5999A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/229,304 US6693081B2 (en) 1995-09-26 1999-01-13 Bone stimulating factor
PCT/CA2000/000031 WO2000042069A1 (en) 1999-01-13 2000-01-13 Bone stimulating factor

Publications (1)

Publication Number Publication Date
IS5999A true IS5999A (is) 2001-07-11

Family

ID=22860649

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5999A IS5999A (is) 1999-01-13 2001-07-11 Beinvaxtarörvandi þáttur

Country Status (19)

Country Link
US (2) US6693081B2 (is)
EP (1) EP1161450A1 (is)
JP (1) JP2002538775A (is)
KR (1) KR20010101425A (is)
CN (1) CN1341120A (is)
AU (1) AU779261B2 (is)
BG (1) BG105682A (is)
BR (1) BR0007816A (is)
CA (1) CA2358908A1 (is)
CZ (1) CZ20012456A3 (is)
HU (1) HUP0105004A2 (is)
IL (1) IL143990A0 (is)
IS (1) IS5999A (is)
MA (1) MA25594A1 (is)
MX (1) MXPA01007043A (is)
NO (1) NO20013257L (is)
NZ (1) NZ512637A (is)
PL (1) PL349786A1 (is)
WO (1) WO2000042069A1 (is)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693081B2 (en) * 1995-09-26 2004-02-17 Osteopharm Inc. Bone stimulating factor
AU5379200A (en) * 1999-06-02 2000-12-28 Osteopharm Inc. Bone stimulating factor
EP1520155A1 (en) * 2002-07-05 2005-04-06 Gaspardo Seminatrici S.P.A. Volumetric metering device for the metered delivery of granular and powdery materials
AU2003272814A1 (en) 2003-10-02 2005-05-19 Ibrahim Al-Habdan Peptide for promoting healing of fractures
WO2012168484A1 (en) * 2011-06-10 2012-12-13 Université Libre de Bruxelles Targets and agents for the treatment of impaired bone fracture healing
CN103159762B (zh) * 2013-03-25 2015-04-15 华东理工大学 表吲哚二酮衍生物及其用途

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320118A (en) 1980-12-22 1982-03-16 Syntex (U.S.A.) Inc. Deca-, undeca-, dodeca- and tridecapeptides with thymic activity
US4897348A (en) 1983-08-25 1990-01-30 Sri International Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof
US4877864A (en) 1987-03-26 1989-10-31 Genetics Institute, Inc. Osteoinductive factors
US5354557A (en) 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
US4950483A (en) 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5024841A (en) 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US5510418A (en) 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5264214A (en) 1988-11-21 1993-11-23 Collagen Corporation Composition for bone repair
AU634508B2 (en) 1988-12-08 1993-02-25 Sandoz Ag Neutrophil-activating peptide-2
US5461034A (en) 1989-02-23 1995-10-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Osteogenic growth polypeptides identified from regenerating bone marrow
CA2075196A1 (en) 1990-02-01 1991-08-02 Gary R. Grotendorst Leukocyte-derived growth factor
CA2040264A1 (en) 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
WO1992009300A1 (en) 1990-11-21 1992-06-11 Iterex Pharmaceuticals Ltd. Partnership Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
ATE164167T1 (de) * 1990-12-21 1998-04-15 Curative Tech Inc Angiogene peptide
US5776892A (en) * 1990-12-21 1998-07-07 Curative Health Services, Inc. Anti-inflammatory peptides
US5208219A (en) 1991-02-14 1993-05-04 Celtrix Pharmaceuticals Inc. Method for inducing bone growth
EP0499242B1 (en) 1991-02-15 1996-06-26 Takeda Chemical Industries, Ltd. Stimulation of endosteal bone formation with a cell growth factor
EP0504938A3 (en) 1991-03-22 1993-04-14 Suntory Limited Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
US5792664A (en) 1992-05-29 1998-08-11 The Rockefeller University Methods for producing and analyzing biopolymer ladders
EP1170300A1 (en) * 1992-07-13 2002-01-09 Bionebraska, Inc. Method for modification of recombinant polypeptides
US5304542A (en) 1992-08-28 1994-04-19 University Of Louisville Research Foundation, Inc. Use of platelet factor 4 to inhibit osteoblast proliferation
IL108947A0 (en) 1993-03-12 1994-06-24 Osteopharm Ltd Bone stimulating factor
US5578569A (en) 1993-03-12 1996-11-26 Tam; Cherk S. Method of increasing bone growth
US5786327A (en) 1993-03-12 1998-07-28 Gensci Regeneration Sciences Inc. Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
US5661127A (en) 1995-05-01 1997-08-26 The Regents Of The University Of California Peptide compositions with growth factor-like activity
US6117839A (en) 1995-06-07 2000-09-12 Gensci Regeneration Sciences, Inc. Bone stimulating factor
US5880094A (en) 1995-06-07 1999-03-09 Osteopharm Limited Polypeptides that stimulate bone growth
US6352973B1 (en) 1995-06-07 2002-03-05 Osteopharm Inc. Bone stimulating factor
ZA968062B (en) 1995-09-26 1997-06-18 Osteopharm Ltd Bone stimulating factor
US6693081B2 (en) * 1995-09-26 2004-02-17 Osteopharm Inc. Bone stimulating factor

Also Published As

Publication number Publication date
IL143990A0 (en) 2002-04-21
AU779261B2 (en) 2005-01-13
HUP0105004A2 (hu) 2002-04-29
AU3028200A (en) 2000-08-01
NZ512637A (en) 2003-08-29
US6693081B2 (en) 2004-02-17
BG105682A (en) 2003-04-30
JP2002538775A (ja) 2002-11-19
MXPA01007043A (es) 2002-03-27
KR20010101425A (ko) 2001-11-14
CZ20012456A3 (cs) 2002-02-13
NO20013257L (no) 2001-08-17
US20020090671A1 (en) 2002-07-11
CN1341120A (zh) 2002-03-20
MA25594A1 (fr) 2002-12-31
EP1161450A1 (en) 2001-12-12
BR0007816A (pt) 2002-12-31
US20040147450A1 (en) 2004-07-29
CA2358908A1 (en) 2000-07-20
NO20013257D0 (no) 2001-06-29
PL349786A1 (en) 2002-09-09
WO2000042069A1 (en) 2000-07-20

Similar Documents

Publication Publication Date Title
DE69929513D1 (de) Knochenprothese
DE60015879D1 (de) Wirbelsäulenimplantat
ATE388677T1 (de) Zwischenwirbelimplantat
DE50010727D1 (de) Flächiges Implantat
DE50010295D1 (de) Zwischenwirbel-nucleus-prothese
DE69914343D1 (de) Medizinisches implantat
DE60028849D1 (de) Sterilisationsmethode
DE69934298D1 (de) Wachstumsfaktoren enthaltende prothesen
FR2775183B1 (fr) Prothese inter-epineuse
FR2780269B1 (fr) Implant rachidien
DE60033691D1 (de) Streifenförmiges implantat
DE69910684D1 (de) Chirurgisches Markierungsimplantat
DE60127333D1 (de) Wirbelsäulenimplantat
DK1333853T3 (da) Vækstfaktorkompleks
FR2794019B1 (fr) Implant d'osteosynthese
DE50001690D1 (de) Chirurgisches Cerclageband
FR2799116B1 (fr) Implant intervertebral
DK1223887T3 (da) Implantatindstilling
ATE309838T1 (de) Pharmazeutisches implantat
NO990937L (no) Kunstig rev
DE60029273D1 (de) Titan-Tinoxidfilme
FR2798583B1 (fr) Implant cotyloidien
IS5999A (is) Beinvaxtarörvandi þáttur
ITMI20000210A0 (it) Protesi cotiloidea
ATE267555T1 (de) Prothesensystem